RCMNY
Rubric Capital Management (New York) Portfolio holdings
AUM
$8.36B
1-Year Est. Return
49.23%
This Fund
S&P 500
1 Year Est. Return
+49.23%
AUM
$7.45B
AUM Growth
+$1.23B
(+20%)
Holding
84
Top Buys
| 1 | +$95.7M | |
| 2 | +$83.4M | |
| 3 | +$77M | |
| 4 |
Newell Brands
NWL
|
+$73.7M |
| 5 |
Eos Energy Enterprises
EOSE
|
+$70.5M |
Top Sells
| 1 | +$326M | |
| 2 | +$276M | |
| 3 | +$73.6M | |
| 4 |
Adaptive Biotechnologies
ADPT
|
+$72.9M |
| 5 |
COOP
Mr. Cooper
COOP
|
+$50.4M |
Sector Composition
| 1 | Healthcare | 36.98% |
| 2 | Utilities | 25% |
| 3 | Industrials | 15.36% |
| 4 | Energy | 6.88% |
| 5 | Financials | 4.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TLN
1
Talen Energy Corp
TLN
$16.4B
| $1.53B | 20.58% |
3,602,171
-903,131
|
|
||
2
FTAI Aviation
FTAI
$30.5B
| $561M | 7.53% |
3,360,553
-33,527
|
|
||
3
Teva Pharmaceuticals
TEVA
$39.2B
| $498M | 6.69% |
24,650,000
-1,350,000
|
|
||
4
Golar LNG
GLNG
$4.61B
| $371M | 4.98% |
9,178,978
|
|
||
5
Roivant Sciences
ROIV
$20.3B
| $303M | 4.06% |
20,000,000
-370,336
|
|
||
6
TransAlta
TAC
$4.12B
| $218M | 2.93% |
15,948,451
|
|
||
7
Arcutis Biotherapeutics
ARQT
$3.04B
| $203M | 2.72% |
10,749,457
|
|
||
8
Fluor
FLR
$7.46B
| $189M | 2.54% |
4,500,000
+500,000
|
|
||
9
Mercury Insurance
MCY
$5.02B
| $174M | 2.34% |
2,054,504
|
|
||
10
BGC Group
BGC
$4.64B
| $170M | 2.29% |
18,000,000
+994,418
|
|
||
11
Kiniksa Pharmaceuticals
KNSA
$3.4B
| $155M | 2.09% |
4,000,000
+90,194
|
|
||
12
Viatris
VTRS
$17.5B
| $152M | 2.05% |
15,385,000
+3,385,000
|
|
||
13
QuidelOrtho
QDEL
$1.51B
| $137M | 1.83% |
4,637,738
|
|
||
14
Amneal Pharmaceuticals
AMRX
$4.25B
| $123M | 1.66% |
12,334,941
+624,609
|
|
||
|
15
Eos Energy Enterprises
EOSE
$1.93B
| $117M | 1.58% |
+10,300,000
|
|
||
16
ReNew
RNW
$2.01B
| $111M | 1.49% |
14,438,061
|
|
||
17
Integra LifeSciences
IART
$820M
| $110M | 1.47% |
7,653,934
+300,000
|
|
||
18
Schrodinger
SDGR
$896M
| $106M | 1.42% |
5,268,817
+268,817
|
|
||
19
Collegium Pharmaceutical
COLL
$1.33B
| $98.9M | 1.33% |
2,826,498
-331,245
|
|
||
20
Ecovyst
ECVT
$1.29B
| $91.1M | 1.22% |
10,400,000
+5,692,653
|
|
||
21
Liberty Global Class A
LBTYA
$4.2B
| $88.8M | 1.19% |
7,750,367
+2,058,142
|
|
||
22
Stratasys
SSYS
$816M
| $87.4M | 1.17% |
7,803,097
|
|
||
23
Delek US
DK
$2.49B
| $86.7M | 1.16% |
2,687,449
|
|
||
24
Liberty Latin America Class C
LILAK
$1.57B
| $86.6M | 1.16% |
+10,256,935
|
|
||
25
Baxter International
BAX
$10.1B
| $86M | 1.15% |
+3,774,889
|
|